Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland

Journal of Clinical Microbiology

Volumn 35, Issue 12, 1997, Pages 3274-3277

  Villano, Stephen A ^a   Vlahov, David ^b   Nelson, Kenrad E ^b   Lyles, Cynthia M ^b   Cohn, Sylvia ^b   Thomas, David L ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ARTICLE; DRUG ABUSE; DRUG USE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; INCIDENCE; INJECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SEROCONVERSION; UNITED STATES;

HEPATITIS C VIRUS;

EID: 0030657897     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.12.3274-3277.1997     Document Type: Article

References (26)

1. Alter, M. J. 1995. Epidemiology of hepatitis C in the West. Semin. Liver Dis. 15:5-14.
2. Alter, M. J., S. C. Hadler, F. N. Judson, A. Mares, W. J. Alexander, P. Y. Hu, J. K. Miller, L. A. Moyer, H. A. Fields, and D. W. Bradley. 1990. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 264:2231-2235.
3. Alter, M. J., H. S. Margolis, K. Krawczynski, F. N. Judson, A. Mares, W. J. Alexander, P. Y. Hu, J. K. Miller, M. A. Gerber, R. E. Sampliner, et al. 1992. The natural history of community acquired hepatitis C in the United States. N. Engl. J. Med. 327:1899-1905.
4. Anonymous. 1994. Hepatitis surveillance report no. 55, p. 1. Centers for Disease Control and Prevention, Atlanta, Ga.
5. Breslow, N. E., and N. E. Day. 1987. Statistical methods in cancer research, vol. 2. Design and analysis of cohort studies. International Agency for Research in Cancer, Lyon, France.
6. Cacopardo, B., F. Fatuzzo, S. Cosentino, B. M. Celesia, M. T. Mughini, R. La Rosa, S. Bruno, G. Lupo, F. Zipper, and G. La Medica. 1992. HCV and HIV infection among intravenous drug abusers in eastern Sicily. Arch. Virol. Suppl. 4:333-334.
7. Chamot, E., P. de Saussure, B. Hirschel, J. J. Deglon, and L. H. Perrin. 1992. Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme. AIDS 6:430-431.
8. Di Bisceglie, A. M., Z. D. Goodman, K. G. Ishak, J. H. Hoofnagle, J. J. Melpolder, and H. J. Alter. 1991. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 14:969-974.
9. Donahue, J. G., K. E. Nelson, A. Muñoz, D. Vlahov, L. L. Rennie, E. L. Taylor, A. J. Saah, S. Cohn, N. J. Odaka, and H. Farzadegan. 1991. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am. J. Epidemiol. 134:1206-1211.
10. Galeazzi, B., A. Tufano, E. Barbierato, and F. Bortolotti. 1995. Hepatitis C virus infection in Italian intravenous drug users: epidemiological and clinical aspects. Liver 15:209-212.
11. Garfein, R. S., M. C. Doherty, D. Brown, D. L. Thomas, S. A. Villano, E. Monterroso, and D. Vlahov. 1996. Hepatitis C virus infection among short-term injection drug users, p. 327. In Empowering the disadvantaged: social justice in public health. American Public Health Association, Washington, D.C.
12. Gerberding, J. L. 1994. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study. J. Infect. Dis. 170:1410-1417.
13. Hagan, H., D. C. D. Jarlais, S. R. Friedman, D. Purchase, and M. J. Alter. 1995. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am. J. Public Health 85:1531-1537.
14. Kiyosawa, K., T. Sodeyama, E. Tanaka, Y. Gibo, K. Yoshizawa, Y. Nakano, S. Furuta, Y. Akahane, K. Nishioka, and R. H. Purcell. 1990. Interrelationship of blood transfusion, non-A. non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12:671-675.
15. Kiyosawa, K., T. Sodeyama, E. Tanaka, Y. Nakano, S. Furuta, K. Nishioka, R. H. Purcell, and H. J. Alter. 1991. Hepatitis C in hospital employees with needlestick injuries. Ann. Intern. Med. 115:367-369.
16. Levine, O. S., D. Vlahov, R. Brookmeyer, S. Cohn, and K. E. Nelson. 1996. Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users. J. Infect. Dis. 173:579-583.
17. Miller, R. G., G. Gong, and A. Muñoz. 1981. Survival analysis. John Wiley and Sons, Inc., New York, N.Y.
18. Mitsui, T., K. Iwano, K. Masuko, C. Yamazaki, H. Okamoto, F. Tsuda, T. Tanaka, and S. Mishiro. 1992. Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 16:1109-1114.
19. Nelson, K. E., D. Vlahov, L. Solomon, S. Cohn, and A. Muñoz. 1995. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md. Arch. Intern. Med. 155:1305-1311.
20. Rezza, G., L. Sagliocca, M. Zaccarelli, M. Nespoli, M. Siconolfi, and C. Baldassarre. 1996. Incidence rate and risk factors for HCV seroconversion among injection drug users in an area with low HIV seroprevalence. Scand. J. Infect. Dis. 28:27-29.
21. Seeff, L. B., G. W. Beebe, J. H. Hoofnagle, J. E. Norman, Z. Buskell-Bales, J. G. Waggoner, N. Kaplowitz, R. S. Koff, J. L. Petrini, E. R. Schiff, et al. 1987. A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. N. Engl. J. Med. 316:965-970.
22. Terrault, N. A., and T. L. Wright. 1995. Hepatitis C virus in the setting of transplantation. Semin. Liver Dis. 15:92-100.
23. Thomas, D. L., D. Vlahov, L. Solomon, S. Cohn, E. Taylor, R. Garfein, and K. E. Nelson. 1995. Correlates of hepatitis C virus infections among injection drug users in Baltimore. Medicine 74:212-220.
24. Tong, M. J., N. S. El-Farra, A. R. Reikes, and R. L. Co. 1995. Clinical outcomes after transfusion-associated hepatitis C. N. Engl. J. Med. 332: 1463-1466.
25. Van Ameijden, E. J., J. A. van den Hoek, G. H. Mientjes, and R. A. Coutinho. 1993. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur. J. Epidemiol. 9:255-262.
26. Vlahov, D., J. C. Anthony, A. Muñoz, J. Margolik, D. D. Celentano, L. Solomon, and B. F. Polk. 1991. The ALIVE study: a longitudinal study of HIV-1 infection in intravenous drug users: description of methods. J. Drug Issues 21:759-776.